Novo Nordisk A/S (NVO)
39.60
-7.82
(-16.49%)
USD |
NYSE |
Feb 23, 15:41
Novo Nordisk Price : 39.60 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 230.15 |
| Evaxion AS | 3.22 |
| Regeneron Pharmaceuticals, Inc. | 783.75 |
| Viking Therapeutics, Inc. | 34.11 |
| DBV Technologies SA | 21.21 |
Price Related Metrics
| PE Ratio | 11.42 |
| PS Ratio | 3.771 |
| PEG Ratio | 2.022 |
| Price to Book Value | 7.612 |
| Price to Free Cash Flow | 40.05 |
| Earnings Yield | 8.76% |
| Market Cap | 176.09B |
| PEGY Ratio | 1.229 |
| Operating PE Ratio | 9.159 |
| Normalized PE Ratio | 11.42 |